Literature DB >> 813077

[Intra- or Postoperative Chemoprophylaxis? (author's transl)].

H J Senn.   

Abstract

The surgical cure rates for most operable cancers have remained unchanged over the past few decades despite progress in local treatment and "prophylactic" preor postoperative radiotherapy. Due to the limitations of primary and secondary prophylaxis (prevention and "early" diagnosis), tertiary prophylaxis (adjuvant chemotherapy to prevent relapse or dissemination) has aroused considerable interest in tumor management recently. Definite progress in prolongation of the postoperative tumorfree interval has been obtained in controlled studies of breast cancer, osteogenic sarcomas and other target neoplasms. Long-term chemoprophylaxis has proved to be more effective than peroperative short courses of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 813077     DOI: 10.1007/BF01257494

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  18 in total

1.  [Progress in the chemotherapy of metastasizing breast and bronchial carcinomas].

Authors:  H J Senn
Journal:  Z Allgemeinmed       Date:  1975-01-31

2.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Authors:  N Jaffe; E Frei; D Traggis; Y Bishop
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

3.  [Significance of bone marrow puncture and the radiological state of the skeleton in the demonstration of osseous neoplasm metastases. Examination of 116 patients with solid tumors].

Authors:  H J Dick; H J Senn; A C Mayr; R Hünig
Journal:  Schweiz Med Wochenschr       Date:  1974-09-14

4.  Amputation and adriamycin in primary osteosarcoma.

Authors:  E P Cortes; J F Holland; J J Wang; L F Sinks; J Blom; H Senn; A Bank; O Glidewell
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

5.  [Therapy of acute leukemias].

Authors:  W F Jungi
Journal:  Schweiz Med Wochenschr       Date:  1973-09-22

6.  [Possibilities and limits of neoplasm drug therapy].

Authors:  H J Senn
Journal:  Schweiz Rundsch Med Prax       Date:  1972-07-04

7.  Unfavourable effects of long-term adjuvant chemotherapy with Endoxan in radically operated bronchogenic carcinoma.

Authors:  K W Brunner; T Marthaler; W Müller
Journal:  Eur J Cancer       Date:  1971-08       Impact factor: 9.162

8.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

9.  Ovarian carcinoma: improvement in survival time after chemotherapy.

Authors:  E B Nye
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-06

10.  Preliminary report from the Scandinavian adjuvant chemotherapy study group.

Authors:  R Nissen-Meyer; K Kjellgren; B Mansson
Journal:  Cancer Chemother Rep       Date:  1971-12
View more
  1 in total

1.  [Intraarterial bleomycin therapy on squamous cell carcinomas of the oral cavity. Clinico-pathological investigations (author's transl)].

Authors:  W J Höltje; A Burkhardt; J O Gebbers; R Maerker
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.